Search

Your search keyword '"Beringer, Paul"' showing total 225 results

Search Constraints

Start Over You searched for: Author "Beringer, Paul" Remove constraint Author: "Beringer, Paul"
225 results on '"Beringer, Paul"'

Search Results

2. Pharmacokinetic Enhancement of Elexacaftor/Tezacaftor/Ivacaftor for Cystic Fibrosis: A Cost Reduction Strategy to Address Global Disparities in Access.

3. Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa

7. Safety of elexacaftor/tezacaftor/ivacaftor dose reduction: Mechanistic exploration through physiologically based pharmacokinetic modeling and a clinical case series

16. Corrigendum to: Enhanced brain delivery and therapeutic activity of trastuzumab after blood-brain barrier opening by NEO100 in mouse models of brain-metastatic breast cancer

17. Drug-drug interactions involving CFTR modulators: a review of the evidence and clinical implications

18. Interdisciplinary Implementation of Mental Health Screenings and Treatment in a Human Immunodeficiency Virus (HIV) Clinic at a Federal Health Care Center

24. Development of a cystic fibrosis population model for physiologically based pharmacokinetic models: Is it worth it?

25. Probenecid, but Not Cystic Fibrosis, Alters the Total and Renal Clearance of Fexofenadine

27. Enhanced brain delivery and therapeutic activity of trastuzumab after blood-brain barrier opening by NEO100 in mouse models of brain-metastatic breast cancer

45. Suppression and resolution of autoimmune arthritis by rhesus θ-defensin-1, an immunomodulatory macrocyclic peptide

47. Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation

49. Rhesus θ-defensin-1 (RTD-1) exhibitsin vitroandin vivoactivity against cystic fibrosis strains ofPseudomonas aeruginosa

Catalog

Books, media, physical & digital resources